| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Nuclear receptor subfamily 2 group C member 2 |
|---|
| Ligand | BDBM439305 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | In Vitro Activity Assay |
|---|
| IC50 | 92.0±n/a nM |
|---|
| Citation |  Treon, SP; Buhrlage, SJ; Gray, NS; Tan, L; Yang, G Methods to treat lymphoplasmacytic lymphoma US Patent US10633348 Publication Date 4/28/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Nuclear receptor subfamily 2 group C member 2 |
|---|
| Name: | Nuclear receptor subfamily 2 group C member 2 |
|---|
| Synonyms: | NR2C2 | NR2C2_HUMAN | Nuclear receptor subfamily 2 group C member 2 | Nuclear receptor subfamily 2 group C member 2 (TAK1) | TAK1 | TR4 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 65411.75 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1476357 |
|---|
| Residue: | 596 |
|---|
| Sequence: | MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAG
TGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVC
GDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEM
GMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLL
DPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ
PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGP
LLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVR
ACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCN
SMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYRL
ARILVRLPALRLMSSNITEELFFTGLIGNVSIDSIIPYILKMETAEYNGQITGASL
|
|
|
|---|
| BDBM439305 |
|---|
| n/a |
|---|
| Name | BDBM439305 |
|---|
| Synonyms: | US10633348, Compound (A-3) |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C30H33F3N6O3 |
|---|
| Mol. Mass. | 582.6166 |
|---|
| SMILES | CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4cc(NC(=O)C5CC5)ncn4)c3)cc2C(F)(F)F)CC1 |
|---|
| Structure | 
|
|---|
Search and Browse
